...
search icon
brtx-img

BioRestorative Therapies Inc, Common Stock

BRTX

NAQ

$1.805

+$0.02

(1.12%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$13.17M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
12.78K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
76.59
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.03 L
$2.55 H
$1.805

About BioRestorative Therapies Inc, Common Stock

BioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells. It develops programs relate to the treatment of disc/spine disease and metabolic disorders. The company's products pipeline comprises BRTX-100, a lead cell therapy candidate formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow, as well as used for the non-surgical treatment of painful lumbosacral disc disorders or as a complimentary therapeutic to a surgical procedure; and ThermoStem, a cell-based therapy candidate to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue. It also operates a commercial biocosmeceutical platform. In addition, the company provides investigational curved needle device to deliver cells and/or other therapeutic products or material to the spine and discs, and other parts of the body. BioRestorative Therapies, Inc. has a research and development agreement with Rohto Pharmaceutical Co., Ltd.; a research agreement with Pfizer, Inc.; and a research collaboration agreement with the University of Pennsylvania. The company was formerly known as Stem Cell Assurance, Inc. and changed its name to BioRestorative Therapies, Inc. in August 2011. BioRestorative Therapies, Inc. is headquartered in Melville, New York. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameBRTXSectorS&P500
1-Week Return2.85%0.35%0.61%
1-Month Return1.4%-0.91%6.14%
3-Month Return19.54%-10.83%3.5%
6-Month Return21.14%-7.74%-2.46%
1-Year Return52.97%-9%10.92%
3-Year Return-62.16%2.52%44.02%
5-Year Return351.25%28.09%83.43%
10-Year Return-99.99%79.95%185.22%

Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue77.00K46.00K119.80K145.80K401.00K[{"date":"2020-12-31","value":19.2,"profit":true},{"date":"2021-12-31","value":11.47,"profit":true},{"date":"2022-12-31","value":29.88,"profit":true},{"date":"2023-12-31","value":36.36,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue-205.21K280.67K165.74K28.07K[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":73.11,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":59.05,"profit":true},{"date":"2024-12-31","value":10,"profit":true}]
Gross Profit77.00K(159.21K)(160.87K)(19.93K)372.93K[{"date":"2020-12-31","value":20.65,"profit":true},{"date":"2021-12-31","value":-42.69,"profit":false},{"date":"2022-12-31","value":-43.14,"profit":false},{"date":"2023-12-31","value":-5.35,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin100.00%(346.10%)(134.28%)(13.67%)93.00%[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-346.1,"profit":false},{"date":"2022-12-31","value":-134.28,"profit":false},{"date":"2023-12-31","value":-13.67,"profit":false},{"date":"2024-12-31","value":93,"profit":true}]
Operating Expenses2.83M26.35M18.98M15.37M11.93M[{"date":"2020-12-31","value":10.73,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":72.03,"profit":true},{"date":"2023-12-31","value":58.31,"profit":true},{"date":"2024-12-31","value":45.26,"profit":true}]
Operating Income(2.75M)(26.31M)(18.97M)(15.22M)(11.56M)[{"date":"2020-12-31","value":-275207600,"profit":false},{"date":"2021-12-31","value":-2630787300,"profit":false},{"date":"2022-12-31","value":-1897402500,"profit":false},{"date":"2023-12-31","value":-1522077400,"profit":false},{"date":"2024-12-31","value":-1155519400,"profit":false}]
Total Non-Operating Income/Expense(10.16M)(19.81M)5.76M5.10M3.19M[{"date":"2020-12-31","value":-176.3,"profit":false},{"date":"2021-12-31","value":-343.74,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":88.41,"profit":true},{"date":"2024-12-31","value":55.38,"profit":true}]
Pre-Tax Income(11.27M)(44.30M)(18.49M)(10.42M)(8.98M)[{"date":"2020-12-31","value":-1127268700,"profit":false},{"date":"2021-12-31","value":-4430329500,"profit":false},{"date":"2022-12-31","value":-1849476900,"profit":false},{"date":"2023-12-31","value":-1041770400,"profit":false},{"date":"2024-12-31","value":-897938100,"profit":false}]
Income Taxes981.99K(14.36M)(479.26K)(5.00)-[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-1462.81,"profit":false},{"date":"2022-12-31","value":-48.8,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes(12.25M)(29.94M)(18.02M)(10.42M)-[{"date":"2020-12-31","value":-1225468000,"profit":false},{"date":"2021-12-31","value":-2993860500,"profit":false},{"date":"2022-12-31","value":-1801551300,"profit":false},{"date":"2023-12-31","value":-1041769900,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(9.96M)(44.30M)(18.49M)(15.94M)(8.98M)[{"date":"2020-12-31","value":-995638300,"profit":false},{"date":"2021-12-31","value":-4430329500,"profit":false},{"date":"2022-12-31","value":-1849476900,"profit":false},{"date":"2023-12-31","value":-1593781900,"profit":false},{"date":"2024-12-31","value":-897938100,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(12.25M)(29.94M)(18.02M)(10.42M)(8.98M)[{"date":"2020-12-31","value":-1225468000,"profit":false},{"date":"2021-12-31","value":-2993860500,"profit":false},{"date":"2022-12-31","value":-1801551300,"profit":false},{"date":"2023-12-31","value":-1041770400,"profit":false},{"date":"2024-12-31","value":-897938100,"profit":false}]
EPS (Diluted)(26.38)(17.00)(2.38)(3.52)(1.21)[{"date":"2020-12-31","value":-2638.34,"profit":false},{"date":"2021-12-31","value":-1700.46,"profit":false},{"date":"2022-12-31","value":-238,"profit":false},{"date":"2023-12-31","value":-352,"profit":false},{"date":"2024-12-31","value":-121.18,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

BRTX
Cash Ratio 2.18
Current Ratio 2.24

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

BRTX
ROA (LTM) -54.17%
ROE (LTM) -117.16%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

BRTX
Debt Ratio Lower is generally better. Negative is bad. 0.40
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.60

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

BRTX
Trailing PE NM
Forward PE NM
P/S (TTM) 34.64
P/B 2.21
Price/FCF NM
EV/R 1.32
EV/Ebitda 0.13
PEG NM

FAQs

What is BioRestorative Therapies Inc share price today?

BioRestorative Therapies Inc (BRTX) share price today is $1.805

Can Indians buy BioRestorative Therapies Inc shares?

Yes, Indians can buy shares of BioRestorative Therapies Inc (BRTX) on Vested. To buy BioRestorative Therapies Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in BRTX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of BioRestorative Therapies Inc be purchased?

Yes, you can purchase fractional shares of BioRestorative Therapies Inc (BRTX) via the Vested app. You can start investing in BioRestorative Therapies Inc (BRTX) with a minimum investment of $1.

How to invest in BioRestorative Therapies Inc shares from India?

You can invest in shares of BioRestorative Therapies Inc (BRTX) via Vested in three simple steps:

  • Click on Sign Up or Invest in BRTX stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in BioRestorative Therapies Inc shares
What is BioRestorative Therapies Inc 52-week high and low stock price?

The 52-week high price of BioRestorative Therapies Inc (BRTX) is $2.55. The 52-week low price of BioRestorative Therapies Inc (BRTX) is $1.03.

What is BioRestorative Therapies Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of BioRestorative Therapies Inc (BRTX) is 2.21

What is the Market Cap of BioRestorative Therapies Inc?

The market capitalization of BioRestorative Therapies Inc (BRTX) is $13.17M

What is BioRestorative Therapies Inc’s stock symbol?

The stock symbol (or ticker) of BioRestorative Therapies Inc is BRTX

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top